How Has the Pediatric Interventional Cardiology Market Size Evolved in Recent Years?
The pediatric interventional cardiology market has seen considerable growth due to a variety of factors.
•The market for pediatric interventional cardiology has significantly expanded in the last few years. The market value is set to increase from $2.44 billion in 2024 to $2.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%.
Several factors have contributed to the growth during the historic period including heightened awareness about mycotoxins, stricter regulatory standards, emphasis on animal health, the globalization of poultry production, market competitiveness, and boosted farm productivity.
What are the Market Size and Expected Growth Rates for the Pediatric Interventional Cardiology Market?
The pediatric interventional cardiology market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to witness robust expansion in the forthcoming years, the pediatric interventional cardiology market is projected to elevate to a size of "$3.61 billion by 2029, registering a compound annual growth rate (CAGR) of 8.3%.
Factors contributing to the prospective growth include the escalating poultry industry, effects of climate change, preference for organic commodities, worldwide trade shifts, governmental strategies, and a rise in health awareness. Key trends forecasted during this period involve the incorporation of technology, enhancement of feed quality and safety, consolidation of the market, cooperative research initiatives, digital transition in farming, and progress in feed technology.
Which Key Drivers Are Propelling The Pediatric Interventional Cardiology Market's Growth?
The growth of the pediatric interventional cardiology market is projected to be fueled by the rising prevalence of congenital heart disease. This condition is characterized by structural abnormalities of the heart present from birth. Pediatric interventional cardiology entails procedures that offer a multitude of advantages over traditional open-heart surgery, for example, shorter recovery spans, decreased infection probability, and minimal scarring. For instance, data from the American Heart Association suggests that approximately 40,000 infants in the United States suffer from congenital heart defects in 2022, with the prevalence of the disease being estimated at 12.3 for every 1000 births in the country. Moreover, according to a 2022 article published by The Lancet, a UK-based general medical journal, congenital heart disease is the most common birth defect, affecting nearly nine out of a thousand live births. Consequently, the escalating occurrence of congenital heart disease is set to propel the expansion of the pediatric interventional cardiology market.
What Are The Key Segments Within The Global Pediatric Interventional Cardiology Market?
The pediatric interventional cardiology market covered in this report is segmented –
1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types
2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures
3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions
Subsegments:
1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR) Devices, Transcatheter Mitral Valve Repair Devices, Transcatheter Pulmonary Valve Replacement Devices
3) By Atherectomy Devices: Directional Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices
4) By Catheters: Diagnostic Catheters, Therapeutic Catheters, Guiding Catheters
5) By Balloons: Balloon Angioplasty Balloons, Intra-Aortic Balloons, High-Pressure Balloons
6) By Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents
7) By Other Device Types: Vascular Closure Devices, Hemodynamic Monitoring Devices, Electrophysiology Devices
Pre-Book The Pediatric Interventional Cardiology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Pediatric Interventional Cardiology Market?
The trend towards product innovation is very apparent within the market for pediatric interventional cardiology. The main players in this field are consistently launching novel, advanced solutions, as a means to bolster their market standing. For instance, Medtronic plc, a medical equipment company originating from the United States, unveiled a new transcatheter pulmonary valve, known as the Harmony Transcatheter Pulmonary Valve System, in February 2023. This Harmony TPV system offers a minimally invasive approach to replacing the open-heart surgical approach, with implantation possible through a small incision in the leg or neck. It is specifically intended for individuals who previously underwent surgical procedures for congenital heart conditions and are experiencing a dysfunctional RVOT (right ventricular outflow tract), due to the previous installment of a conduit or bio prosthetic pulmonary valve. The Harmony TPV system is also suitable for those with a native or patched RVOT who need to have their pulmonary valve replaced.
Who Are the Key Players in the Pediatric Interventional Cardiology Market?
Major companies operating in the pediatric interventional cardiology market include:
• Medtronic plc
• GE HealthCare Technologies Inc.
• Abbott Laboratories
• Terumo Corporation
• W.L. Gore & Associates Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Siemens Healthineers
• Numed Inc.
• St. Jude Medical Inc.
• Cordis Corporation
• Koninklijke Philips N.V.
• Biotronik
• B. Braun Melsungen AG
• Canon Medical Systems Corporation
• Gore & Associates Inc.
• Johnson and Johnson
• Cook Group LLC
• Teleflex Incorporated
• Merit Medical Systems Inc.
• MicroPort Scientific Corporation
• Lepu Medical Technology (Beijing) Co.Ltd.
• Biosensors International Group Ltd.
• Cardiac Science Corporation
• Asahi Intecc Co.Ltd.
• Medinol Ltd.
• Jotec GmbH
• Hexacath Ltd.
• Translumina GmbH
What are the Regional Insights into the Pediatric Interventional Cardiology Market?
North America was the largest region in the pediatric interventional cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
